BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 ...

By Sahil Pandey July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal ...

BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 ...

Why Medical Products Maker Repligen May Be A Potential Buy Repligen (NASDAQ:RGEN) said it has signed a definitive agreement ...

Repligen (NasdaqGS:RGEN) and BioLife Solutions recently held a merger and acquisition call. The discussion focused on ...

"Once again, we delivered excellent results in the second quarter" (President, CEO & Director Olivier Loeillot), citing "12% reported growth," "13% organic growth" and "460 basis points of adjusted ...

Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business BioLife stockholders to ...

Life sciences equipment and consumable manufacturer Repligen has reached a deal to buy cell therapy specialist BioLife ...

Repligen Corporation has finalized a definitive agreement to acquire BioLife Solutions, aiming to significantly expand its ...

Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about US$1.5 billion, to ...

BioLife is a cell- and gene-therapy bioproduction tools and services company. It makes cell-storage media, thawing solutions, cold chain accessories, and cryopreservation freeze media products. Its ...

BioLife CEO Bill Jones calls for a new global health vocabulary, shifting from weight-loss language to biology-driven terms that support metabolic well-being, body positivity, and regenerative care.